1. Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma
    Jia-Lin Yang et al, 2017, International Journal of Molecular Sciences CrossRef
  2. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome
    Silke Reinartz et al, 2016, Genome Biology CrossRef
  3. Ginkgolic Acid C 17:1, Derived from Ginkgo biloba Leaves, Suppresses Constitutive and Inducible STAT3 Activation through Induction of PTEN and SHP-1 Tyrosine Phosphatase
    Seung Baek et al, 2017, Molecules CrossRef
  4. Astaxanthin Inhibits JAK/STAT-3 Signaling to Abrogate Cell Proliferation, Invasion and Angiogenesis in a Hamster Model of Oral Cancer
    J. Kowshik et al, 2014, PLoS ONE CrossRef
  5. Cross Talk between the TM4SF5/Focal Adhesion Kinase and the Interleukin-6/STAT3 Pathways Promotes Immune Escape of Human Liver Cancer Cells
    Jihye Ryu et al, 2014, Molecular and Cellular Biology CrossRef
  6. Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
    Ho-June Lee et al, 2014, Cancer Cell CrossRef
  7. Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3
    Saet-Byul Oh et al, 2014, Cancer Letters CrossRef
  8. LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling
    Yuet Ping Kwan et al, 2021, Cancers CrossRef
  9. Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach
    Ali N. Chamseddine et al, 2021, Pharmacology & Therapeutics CrossRef
  10. STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
    Melanie Spitzner et al, 2014, Cancers CrossRef
  11. Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors
    Matthew G. LaPorte et al, 2016, Bioorganic & Medicinal Chemistry Letters CrossRef
  12. Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
    Ommoleila Molavi et al, 2017, Pharmaceutical Biology CrossRef
  13. An Electrophilic Deguelin Analogue Inhibits STAT3 Signaling in H-Ras-Transformed Human Mammary Epithelial Cells: The Cysteine 259 Residue as a Potential Target
    Sung-Jun Hong et al, 2020, Biomedicines CrossRef
  14. Targeting Tumor–Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer
    Austin R. Dosch et al, 2021, Molecular Cancer Therapeutics CrossRef
  15. Toward a new STATe: The role of STATs in mitochondrial function
    Jeremy A. Meier et al, 2014, Seminars in Immunology CrossRef
  16. IL-6 pathway in the liver: From physiopathology to therapy
    Dirk Schmidt-Arras et al, 2016, Journal of Hepatology CrossRef
  17. Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors
    Steffanie L. Furtek et al, 2016, Oncotarget CrossRef
  18. Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines
    Keisuke Taniguchi et al, 2021, Scientific Reports CrossRef
  19. Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy
    Tzu-Ting Huang et al, 2017, International Journal of Molecular Sciences CrossRef
  20. Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors
    Jianpeng Guo et al, 2018, European Journal of Medicinal Chemistry CrossRef
  21. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts
    Chi Man Tsang et al, 2013, BMC Cancer CrossRef
  22. Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation
    Brian F. Kiesel et al, 2016, Cancer Chemotherapy and Pharmacology CrossRef
  23. At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells
    Uri Rozovski et al, 2016, The Journal of Immunology CrossRef
  24. Down‐regulation of microRNA‐34c‐5p alleviates neuropathic pain via the SIRT1/STAT3 signaling pathway in rat models of chronic constriction injury of sciatic nerve
    Yanshuai Mo et al, 2020, Journal of Neurochemistry CrossRef
  25. The Potential of panHER Inhibition in Cancer
    Xiaochun Wang et al, 2015, Frontiers in Oncology CrossRef
  26. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells
    Ga Bin Park et al, 2019, Neoplasia CrossRef
  27. Taming the immune system through transfusion in oncology patients
    Seyed Mohammad Amin Kormi et al, 2017, Transfusion and Apheresis Science CrossRef
  28. Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer
    Yuhao Ren et al, 2021, Journal of Medicinal Chemistry CrossRef
  29. Physalis alkekengi var. franchetii Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 Signaling
    Yufei Fu et al, 2021, OncoTargets and Therapy CrossRef
  30. Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network
    Guanyi Huang et al, 2015, Cellular and Molecular Life Sciences CrossRef
  31. Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
    S-C Lee et al, 2016, Oncogene CrossRef
  32. Ferulic acid maintains the self-renewal capacity of embryo stem cells and adipose-derived mesenchymal stem cells in high fat diet-induced obese mice
    Jinkyung Cho et al, 2020, The Journal of Nutritional Biochemistry CrossRef
  33. STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer
    Joseph D Fleming et al, 2015, Epigenetics & Chromatin CrossRef
  34. Prognostic Significance of Serine-Phosphorylated STAT3 Expression in pT1-T2 Oral Tongue Carcinoma
    Elena Fasanaro et al, 2015, Clinical and Experimental Otorhinolaryngology CrossRef
  35. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells
    S Carbajo-Pescador et al, 2013, British Journal of Cancer CrossRef
  36. Withaferin A Inhibits STAT3 and Induces Tumor Cell Death in Neuroblastoma and Multiple Myeloma
    Lisette P. Yco et al, 2014, Biochemistry Insights CrossRef
  37. Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer
    Hiroe Nakamura et al, 2016, BMC Cancer CrossRef
  38. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation
    Jinyun Dong et al, 2021, Journal of Medicinal Chemistry CrossRef
  39. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion
    Cuiqi Zhou et al, 2015, Journal of Clinical Investigation CrossRef
  40. STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody
    Ji-Sun Lee et al, 2015, Nature Communications CrossRef
  41. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
    Jaemoo Chun et al, 2015, Cancer Letters CrossRef
  42. STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection
    Miguel S. Gonzalez-Mancera et al, 2020, Respiratory Medicine Case Reports CrossRef
  43. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer
    Zhi Hong Zhang et al, 2020, Phytomedicine CrossRef
  44. Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
    Min Ye et al, 2021, Frontiers in Pharmacology CrossRef
  45. Arylidenes of Quinolin-2-one scaffold as Erlotinib analogues with activities against leukemia through inhibition of EGFR TK/ STAT-3 pathways
    Mohammed A.I. Elbastawesy et al, 2020, Bioorganic Chemistry CrossRef
  46. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer
    XIAOJIAN LIU et al, 2014, Oncology Reports CrossRef
  47. Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway
    Gang Xu et al, 2017, BioMed Research International CrossRef
  48. Albendazole Exhibits Anti-Neoplastic Actions against Gastric Cancer Cells by Affecting STAT3 and STAT5 Activation by Pleiotropic Mechanism(s)
    Min Hee Yang et al, 2021, Biomedicines CrossRef
  49. Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling
    Youn Choi et al, 2017, Marine Drugs CrossRef
  50. Atiprimod induce apoptosis in pituitary adenoma: Endoplasmic reticulum stress and autophagy pathways
    Ajda Coker‐Gurkan et al, 2019, Journal of Cellular Biochemistry CrossRef
  51. Role of Stat3 Activation in Cell-Cell Interaction between B-Cell Lymphoma and Macrophages : The in vitro Study
    Bing Bai et al, 2013, Journal of Clinical and Experimental Hematopathology CrossRef
  52. Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M
    Srinath C. Sampath et al, 2018, Nature Communications CrossRef
  53. Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma
    Amir H. Soleimani et al, 2017, Drug Delivery and Translational Research CrossRef
  54. STAT3 in Cancer—Friend or Foe?
    Hai-Feng Zhang et al, 2014, Cancers CrossRef
  55. Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis
    Yi Qin et al, 2016, Tumor Biology CrossRef
  56. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation
    Hongda Ding et al, 2020, Cellular & Molecular Biology Letters CrossRef
  57. Immune evasion in cancer: Mechanistic basis and therapeutic strategies
    Dass S. Vinay et al, 2015, Seminars in Cancer Biology CrossRef
  58. Virus induced inflammation and cancer development
    Scott A. Read et al, 2014, Cancer Letters CrossRef
  59. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein
    Shanshan Li et al, 2016, European Journal of Medicinal Chemistry CrossRef
  60. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype
    Fanping Kong et al, 2017, PLOS Pathogens CrossRef
  61. bFGF-mediated pluripotency maintenance in human induced pluripotent stem cells is associated with NRAS-MAPK signaling
    Fereshteh Haghighi et al, 2018, Cell Communication and Signaling CrossRef
  62. Screening of Stat3 inhibitory effects of Korean herbal medicines in the A549 human lung cancer cell line
    Jong-Shik Park et al, 2014, Integrative Medicine Research CrossRef
  63. Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle
    Francesca Pretto et al, 2015, Oncotarget CrossRef
  64. A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception
    Kaviarasan Lakshmanan et al, 2020, Current Enzyme Inhibition CrossRef
  65. STAT3 Pathway Is Activated in ALK-positive Large B-cell Lymphoma Carrying SQSTM1-ALK Rearrangement and Provides a Possible Therapeutic Target
    Emanuele S.G. d’Amore et al, 2013, American Journal of Surgical Pathology CrossRef
  66. Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors
    Guiping Cai et al, 2019, European Journal of Medicinal Chemistry CrossRef
  67. The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma
    Jia-Jie Chen et al, 2017, Oncotarget CrossRef
  68. Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
    Khalid Abubaker et al, 2014, Frontiers in Oncology CrossRef
  69. Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
    Uri Rozovski et al, 2015, Molecular Cancer Research CrossRef
  70. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
    Walhan Alshaer et al, 2019, International Journal of Molecular Sciences CrossRef
  71. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells
    Shuwei Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  72. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells
    Sevda Jafari et al, 2020, DARU Journal of Pharmaceutical Sciences CrossRef
  73. STAT3beta, a distinct isoform from STAT3
    Hui-Xiang Zhang et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
  74. Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression
    Yun Hong et al, 2015, Biochemical and Biophysical Research Communications CrossRef
  75. Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors
    Veronika Mancikova et al, 2017, Clinical Cancer Research CrossRef
  76. Evaluation of the Prognostic Role of pSTAT3 Expression in Temporal Bone Squamous Cell Carcinoma
    Gino Marioni et al, 2013, Otology & Neurotology CrossRef
  77. Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells
    Sung-Moo Kim et al, 2014, Cancer Letters CrossRef
  78. The role of STAT3 in tumor-mediated immune suppression
    Sherise D. Ferguson et al, 2015, Journal of Neuro-Oncology CrossRef
  79. AZD1480 Can Inhibit the Biological Behavior of Ovarian Cancer SKOV3 Cells in vitro
    Zhao-Ling Sun et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef
  80. The multifaceted STAT3: How a transcription factor regulates Ca2+ signaling via a degradative pathway
    Jan B. Parys, 2018, Cell Calcium CrossRef
  81. Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo
    Zhe Liu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  82. Trichothecin Inhibits Cancer-Related Features in Colorectal Cancer Development by Targeting STAT3
    Xin Qi et al, 2020, Molecules CrossRef
  83. BP-1-102 and silencing of Fascin-1 by RNA interference inhibits the proliferation of mouse pituitary adenoma AtT20 cells via the signal transducer and activator of transcription 3/fascin-1 pathway
    GuoDong Qian et al, 2021, International Journal of Neuroscience CrossRef
  84. Alternative ways of modulating JAK-STAT pathway
    Olga A. Timofeeva et al, 2012, JAK-STAT CrossRef
  85. 14-3-3ζ Regulates Immune Response through Stat3 Signaling in Oral Squamous Cell Carcinoma
    Xinguang Han et al, 2015, Molecules and Cells CrossRef
  86. Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
    Emily Chan et al, 2018, Oncotarget CrossRef
  87. Costunolide, a Sesquiterpene Lactone, Suppresses Skin Cancer via Induction of Apoptosis and Blockage of Cell Proliferation
    Sung Ho Lee et al, 2021, International Journal of Molecular Sciences CrossRef
  88. SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone
    Martín Garrido-Rodríguez et al, 2019, Journal of Proteomics CrossRef
  89. Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries
    Daniel Sun et al, 2017, Journal of Experimental Medicine CrossRef
  90. Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad
    Ju-Hee Kang et al, 2019, Laboratory Animal Research CrossRef
  91. Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines
    Xiaochun Wang et al, 2018, International Journal of Oncology CrossRef
  92. Identification of new shikonin derivatives as STAT3 inhibitors
    Han-Yue Qiu et al, 2017, Biochemical Pharmacology CrossRef
  93. A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction
    Soo Kyung Park et al, 2020, Biochemical Pharmacology CrossRef
  94. Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma
    Xiaochun Wang et al, 2016, Oncotarget CrossRef
  95. Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma
    TAO XU et al, 2015, Oncology Reports CrossRef
  96. Redox regulation of DUBs and its therapeutic implications in cancer
    Apoorvi Tyagi et al, 2021, Redox Biology CrossRef
  97. Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
    Yunbao Pan et al, 2013, PLoS ONE CrossRef
  98. Development of an HPLC-UV Method for Quantification of Stattic
    Soheil Sedaghat et al, 2019, Current Pharmaceutical Analysis CrossRef
  99. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
    Khalid Abubaker et al, 2014, BMC Cancer CrossRef
  100. Targeting protein–protein interactions (PPIs) of transcription factors: Challenges of intrinsically disordered proteins (IDPs) and regions (IDRs)
    Susan Sammak et al, 2015, Progress in Biophysics and Molecular Biology CrossRef
  101. Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
    Shaoyong Lu et al, 2019, Journal of Medicinal Chemistry CrossRef
  102. Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease
    Jing Pan et al, 2021, Life Sciences CrossRef
  103. IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis
    Rei Nakamura et al, 2015, Nature Communications CrossRef
  104. miR-124 and Parkinson’s disease: A biomarker with therapeutic potential
    Efthalia Angelopoulou et al, 2019, Pharmacological Research CrossRef
  105. The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas
    Xiaochun Wang et al, 2020, Oncotarget CrossRef
  106. 2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway
    Matthew G. LaPorte et al, 2014, Bioorganic & Medicinal Chemistry Letters CrossRef
  107. Novel Thiosemicarbazones Regulate the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway: Inhibition of Constitutive and Interleukin 6–Induced Activation by Iron Depletion
    Goldie Y. L. Lui et al, 2015, Molecular Pharmacology CrossRef
  108. Ursolic acid derivative FZU-03,010 inhibits STAT3 and induces cell cycle arrest and apoptosis in renal and breast cancer cells
    Wei Li et al, 2017, Acta Biochimica et Biophysica Sinica CrossRef
  109. Improved chemosensitivity in cervical cancer to cisplatin: Synergistic activity of mahanine through STAT3 inhibition
    Ranjita Das et al, 2014, Cancer Letters CrossRef
  110. Inhibition of JAK2/STAT3 and activation of caspase‑9/3 are involved in KYS05090S‑induced apoptosis in ovarian cancer cells
    Bo‑Im Kim et al, 2019, International Journal of Oncology CrossRef
  111. Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens
    Kazim Sahin et al, 2018, Journal of Cancer Prevention CrossRef
  112. Inhibition of STAT3 activation by KT-18618 via the disruption of the interaction between JAK3 and STAT3
    Dae-Seop Shin et al, 2014, Biochemical Pharmacology CrossRef
  113. Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells
    Ajda Coker-Gurkan et al, 2021, Molecular Biology Reports CrossRef
  114. MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells
    J-Y Yoo et al, 2018, Oncogene CrossRef
  115. lncRNA TUG1 regulates angiogenesis via the miR‑204‑5p/JAK2/STAT3 axis in hepatoblastoma
    Miao-Xian Yuan et al, 2021, Molecular Medicine Reports CrossRef
  116. Microenvironmental Clues for Glioma Immunotherapy
    Michael Platten et al, 2014, Current Neurology and Neuroscience Reports CrossRef
  117. The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation
    WEI ZHOU et al, 2016, International Journal of Oncology CrossRef
  118. STAT3 Inhibitors as Sensitizing Agents for Cancer Chemotherapy
    Yang Yang et al, 2019, Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy CrossRef
  119. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis
    Martin E. Rottenberg et al, 2014, Seminars in Immunology CrossRef
  120. The transcription factor Gbx2 induces expression of Kruppel-like factor 4 to maintain and induce naïve pluripotency of embryonic stem cells
    Manman Wang et al, 2017, Journal of Biological Chemistry CrossRef
  121. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
    Jenny D. Beebe et al, 2018, Pharmacology & Therapeutics CrossRef
  122. STAT3 isoforms: Alternative fates in cancer?
    Petra Aigner et al, 2019, Cytokine CrossRef
  123. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
    Koji Taniguchi et al, 2014, Seminars in Immunology CrossRef
  124. miR-634 Decreases the Radioresistance of Human Breast Cancer Cells by Targeting STAT3
    Bilan Yang et al, 2020, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  125. Understanding STAT3 signaling in cardiac ischemia
    K. E. O’Sullivan et al, 2016, Basic Research in Cardiology CrossRef
  126. Natural Salicylates and Their Roles in Human Health
    Fatema Yeasmin et al, 2020, International Journal of Molecular Sciences CrossRef
  127. Ganoderic acid A exerts antitumor activity against MDA‑MB‑231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
    Yuguang Yang et al, 2018, Oncology Letters CrossRef